Spotlight on Umoja Biopharma’s Engineered induced Pluripotent Stem Cells (iPSCs) Platform

A Brief History of the CAR T Cell Field While chimeric antigen receptor (CAR) T cell therapies have revolutionized the treatment of blood-forming tissue cancers (i.e., hematologic malignancies), major limitations hinder their widespread application. Decades of CAR T cell therapy efforts, starting with “first generation” CAR T cell therapies in the 1990s and leading to […]